[APLS] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
25-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -11.32%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 396,591 75,422 66,563 250,646 0 0 0 -
PBT -526,496 -651,503 -746,002 -343,029 -304,707 -127,502 -51,006 47.53%
Tax 2,132 669 352 1,845 5,109 -533 251 42.81%
NP -528,628 -652,172 -746,354 -344,874 -309,816 -127,502 -51,006 47.63%
Tax Rate - - - - - - - -
Total Cost 925,219 727,594 812,917 595,520 309,816 127,502 51,006 62.05%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -133.29 -864.70 -1,121.27 -137.59 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -4.45 -6.15 -8.84 -4.59 -4.98 -2.34 -3.68 3.21%
EPS Diluted -4.45 -6.15 -8.84 -4.59 -4.98 -2.34 -3.68 3.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.